v3.26.1
In-Process Research and Development, Net (Tables)
 6 Months Ended
Mar. 31, 2026
In-Process Research and Development, Net [Abstract]  
Schedule of In-Process Research and Development A summary of the expected future amortization expense for LYMPHIR in-process research and development is as follows:
Year Ending September 30,  Amount 
2026 (excluding the six months ended March 31,2026)  $3,440,625 
2027   6,881,250 
2028   6,881,250 
2029   6,881,250 
2030   6,881,250 
2031   6,881,250 
Thereafter   33,259,375 
Total  $71,106,250